By Joey Wong, Investor Research Analyst, Hong Kong BD, LSN
RESI JPM San Francisco 2023 is fast approaching. The Life Science Nation (LSN) team has been busy putting together a program of 8 panels that provides latest insights on early-stage life science and healthcare.
We are excited to have invited a diverse lineup of panelists from different types of investment groups, including Big Pharma, corporate VCs, medtech strategics, traditional VCs, angels and family offices, to share their strategies and approaches on early-stage investment, perspectives on industry landscape, startup ecosystem and more. As a global conference, we are also delighted to have many international investors and cross-border investment groups to join and contribute to these dynamic discussions. The goal of RESI panels is to facilitate constructive conversations between investors and fundraising CEOs, and provide tactical advice on how companies can raise capital and acquire partnerships effectively. These must-see panels are great opportunities for founders and CEOs to engage with investors and kick off their fundraising journey of 2023.
Join the panelists below at RESI JPM San Francisco:
 Mel Barsky Director of Business Development Centre for Aging + Brain Health Innovation (CABHI) |
 Lana Caron Innovation Lead Philips Ventures |
 Bruce Cohen Venture Partner Xeraya Capital |
 Matt Deschner Business Development & Licensing – Surgical Innovations Medtronic |
 Gini Deshpande Partner of Cathay Capital |
 Niels Emmerich Vice President, Global Head Search and Evaluation AbbVie |
 Xi Fang Managing Partner Button Capital |
 Jon Friedland Managing Director, Ventures Cleveland Clinic Ventures |
 Amit Garg Managing Partner Tau Ventures |
 Lana Ghanem Managing Director Hikma Ventures |
 Tom Gibbs Director Debiopharm Innovation Fund |
 Gita Gupta Partner NextStep Ventures |
 Duncan Huston-Paterson Senior Manager, Business Development Amgen |
 Kristin King Member Boston Harbor Angels |
 Fiona Mack VP, Head of CoLaborator Bayer |
 Nola Masterson Managing Director Science Futures |
 Andrew Meadow General Partner Health Innovation Capital |
 Tamir Meiri Senior Manager, Venture Investments Johnson & Johnson Innovation |
 Ole Mensching Co-Founder and General Partner Apollo Health Ventures |
 Ravi Mistry Angel Investor |
 John Parker Founder & Managing Director Springhood Ventures |
 Armin Rump Manager, Global Business Development Otsuka Pharmaceutical |
 Akhil Saklecha Chief Scientific Officer, Acute Care Danaher Corporation |
 Yoke Sin Managing Partner iGlobe Partners |
 Lesley Stolz Regional Vice President, Early Innovation Partnering Johnson & Johnson Innovation |
 Sally Wang Venture Partner Viva BioInnovator |
 Oscar Zhang Principal Qiming Venture Partners |
 Lu Zhang Managing Partner Fusion Fund |
 Cheryl Zimberlin Investment Director M Ventures |
Next Phase Newsletter 
Leave a Reply